API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Atenolol Pellets are formulated to provide a controlled and sustained release of Atenolol, a selective beta-1 adrenergic receptor primarily used in the management of hypertension, angina pectoris, and certain arrhythmias. The pellet form ensures uniform distribution of the drug in the gastrointestinal tract, improving absorption and minimizing dose dumping.
| Component | Function |
|---|---|
| Atenolol | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Eudragit RS / RL or equivalent polymer | Sustained release coating polymer |
| Triethyl Citrate / PEG 6000 | Plasticizer (for enteric coating) |
| Talc | Anti-sticking agent in coating |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Atenolol Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Atenolol SR Pellets are primarily used in the formulation of sustained-release capsules or tablets for managing hypertension, angina pectoris, and certain cardiac arrhythmias.
The product is supplied with Certificate of Analysis (CoA), MSDS, stability data, and GMP compliance documents.
Yes, strength, release profile, and polymer coating can be tailored according to client specifications and regulatory needs.
We export to Asia, Africa, Middle East, CIS countries, and Latin America. For regulated markets (USA, EU), additional compliance and documentation may be required.